Is the assessment of von Willebrand disease prevalence an achievable challenge? The example of the French Basque Country where blood group O and factor XI deficiency are highly prevalent

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 10, 2004, Pages 1724-1726

  Bauduer, Frédéric ^a   Ducout, L ^a  

^a CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

Author keywords

Basques; Blood group O; Factor XI deficiency; Population genetics; von Willebrand disease

Indexed keywords

RISTOCETIN; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD GROUP O; CLINICAL ARTICLE; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; FAMILY HISTORY; FEMALE; FRANCE; GENETIC VARIABILITY; HUMAN; IMMUNOASSAY; MALE; PHENOTYPIC VARIATION; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPTOMATOLOGY; THROMBOCYTE AGGLUTINATION; VON WILLEBRAND DISEASE;

ABO BLOOD-GROUP SYSTEM; FACTOR XI DEFICIENCY; FEMALE; FRANCE; HUMANS; MALE; PREVALENCE; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 13244277501     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00930.x     Document Type: Article

References (12)

1. Rodeghiero F, Castaman G. Congenital von Willebrand disease type 1: definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol 2001; 14: 321-35.
2. Sadler JE. von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
3. Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, Meyer D, Peake I, Rodeghiero F, Srivastava A. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
4. Miller CH, Haff E, Platt SJ, Rawlins P, Drews CD, Dilley AB, Evatt B. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost 2003; 1: 2191-7.
5. Cavalli-Sforza LL, Menozzi P, Piazza A. The History and Geography of Human Genes. Princeton: Princeton University Press 1994.
6. Bauduer F, Ducout L, Degioanni A, Dutour O. Is there a 'Basque' profile regarding autosomal recessive deficiencies of coagulation factors? Haemophilia 2004; 10: 276-9.
7. Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, Seligsohn U. Factor XI deficiency in Basques is predominantly caused by an ancestral C38R mutation in the factor XI gene. Blood 2002; 99: 2448-54.
8. Nitu-Whalley IC, Riddell A, Lee CA, Pasi KJ, Owens D, Enayat MS, Perkins SJ, Jenkins PV. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling. Thromb Haemost 2000; 84: 998-1004.
9. Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 2002; 8: 607-21.
10. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
11. Bauduer F, Degioanni A, Desmoulins I, Hoyrup A, Cabantous A, Molinier C, Dutour O. Is there still a ABO and Rhesus blood groups specificity within the French Basque Country and the 'Aquitany perimeter' at the beginning of the 21st Century? Bull Mem Soc Anthropol Paris 2002; 14: 198-9.
12. Orstavik K, Magnus P, Reisner H, Berg K, Graham J, Nance W. Factor VIII and factor IX in a twin population: evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.